DUSPATALIN RETARD CAPSULE 200 mg

Šalis: Singapūras

kalba: anglų

Šaltinis: HSA (Health Sciences Authority)

Veiklioji medžiaga:

MEBEVERINE HCl

Prieinama:

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

ATC kodas:

A03AA04

Dozė:

200 mg

Vaisto forma:

CAPSULE

Sudėtis:

MEBEVERINE HCl 200 mg

Vartojimo būdas:

ORAL

Recepto tipas:

Pharmacy Only

Pagaminta:

ABBOTT BIOLOGICALS B.V.

Autorizacija statusas:

ACTIVE

Leidimo data:

1994-03-10

Pakuotės lapelis

DUSPATALIN® RETARD 200 MG,
modified release capsules, hard
200 mg mebeverine hydrochloride
Read this entire leaflet carefully before you start taking this
medicine. Keep this leaflet. You may need
to read it again. If you have further questions, please ask your
doctor or pharmacist. This medicine
has been prescribed for you personally and you should not pass it on
to others. It may harm them,
even if their symptoms are the same as yours.
Duspatalin retard 200 mg modified release capsules are opaque white,
hard gelatine capsules, with the
imprint 245 on one side. The capsules are for oral administration only
(to be taken by mouth). Each
capsule contains 200 mg mebeverine hydrochloride.
Excipients (non-medicinal ingredients):
Capsule content (granules):
Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose,
methacrylic acid - ethyl acrylate
copolymer (1:1) dispersion 30%, glycerol triacetate
Capsule shell: Gelatine, titanium dioxide (E171), Printing ink:
shellac (E904), black iron oxide (E172,)
propylene glycol, concentrated ammonia solution, potassium hydroxide.
INDICATIONS
Symptomatic treatment of abdominal pain and cramps, bowel disturbances
and intestinal discomfort
related to irritable bowel syndrome.
Treatment of gastro-intestinal spasm secondary to organ diseases.
DOSAGE AND ADMINISTRATION
Adults
Take one capsule twice daily, one in the morning and one in the
evening.
The capsules should be swallowed with a sufficient amount of water (at
least 100 ml of water). They
should not be chewed because the coating is intended to ensure a
prolonged release mechanism.
Treatment Duration
Symptom relief occurs after a minimum of 2 to 4 weeks of treatment and
greater effects can be
observed after a prolonged therapy of 6 to 8 weeks.
Always take Duspatalin retard exactly as your doctor has prescribed.
If you have any questions, check
with your doctor or pharmacist.
In case of one or more dose(s) is (are) missed, you should continue
with the next dose as prescribed; the
missed dose(s) is (are) not to be take